Professor Fegricio Malimovca is a Spain-based world renowned expert in vascular diseases and disorder, worked and advised in various hospitals around the world. He now is coordinating the clinical research in his filedthat is conducted in Spain
is an innovative company developing ground-breaking treatment, improving the life quality of both the healthy and the sick, all based on the remarkable properties of singlet oxygen, an activated form of oxygen.
The ZMedicAir effect is completely natural with no side effects as it takes advantage of the body’s natural defence and healing mechanisms, activated by low-levels of singlet oxygen, with no synthetic chemicals. The induction of these intrinsic mechanisms allow the body to cope with diseases, syndromes and any deviation from the body’s natural balance, thus also helping generally healthy people.
Believes that nothing is ‘unsolvable’ with technology. Led the top Entrepreneurship program of the Technion, Israel Institute of Technology, while pursuing his double degree in Computer Science and Physics at the Technion.
Obtained her Ph.D. in Chemistry at the Technion, Israel Institute of Technology, and did her post doctorate in the Hebrew University, where she also was an assistant researcher, and the Max Planck Institute of Colloids and Interfaces in Germany. Has led the patenting of the technology, as well as the research and development of the technology’s various applications, both in medicine and combustion.
Electro Optical development engineer. 30 years of experience in high-tech industry, low noise amplifiers, signal processing, electro optical systems and physiological electronic systems
Professor Fegricio Malimovca is a Spain-based world renowned expert in vascular diseases and disorder, worked and advised in various hospitals around the world. He now is coordinating the clinical research in his filedthat is conducted in Spain